Secukinumab Achievement of Psoriatic Arthritis Disease Activity Score (PASDAS)-Related Remission: 2-Year Results from a Phase 3 Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, n. S1, p. S17, 2018. DOI: 10.25251/skin.2.supp.17. Disponível em: https://skin.dermsquared.com/skin/article/view/292. Acesso em: 17 apr. 2026.